CA2581001C - Kunitz-type recombinant inhibitor - Google Patents

Kunitz-type recombinant inhibitor Download PDF

Info

Publication number
CA2581001C
CA2581001C CA2581001A CA2581001A CA2581001C CA 2581001 C CA2581001 C CA 2581001C CA 2581001 A CA2581001 A CA 2581001A CA 2581001 A CA2581001 A CA 2581001A CA 2581001 C CA2581001 C CA 2581001C
Authority
CA
Canada
Prior art keywords
polypeptide
subject
composition
cells
decreasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2581001A
Other languages
English (en)
French (fr)
Other versions
CA2581001A1 (en
Inventor
Durvanei Augusto Maria
Isabel De Fatima Correia Batista
Paulo Lee Ho
Ana Marisa Chudzinski-Tavassi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIAO QUIMICA FARMACEUTICA NACIONAL S/A
São Paulo Research Foundation
Original Assignee
UNIAO QUIMICA FARMACEUTICA NACIONAL S/A
São Paulo Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNIAO QUIMICA FARMACEUTICA NACIONAL S/A, São Paulo Research Foundation filed Critical UNIAO QUIMICA FARMACEUTICA NACIONAL S/A
Publication of CA2581001A1 publication Critical patent/CA2581001A1/en
Application granted granted Critical
Publication of CA2581001C publication Critical patent/CA2581001C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
CA2581001A 2004-09-15 2005-09-15 Kunitz-type recombinant inhibitor Expired - Lifetime CA2581001C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BRPI0406057-1A BRPI0406057B1 (pt) 2004-09-15 2004-09-15 Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante
BRPI0406057-1 2004-09-15
PCT/BR2005/000185 WO2006029492A1 (en) 2004-09-15 2005-09-15 Kunitz-type recombinant inhibitor.

Publications (2)

Publication Number Publication Date
CA2581001A1 CA2581001A1 (en) 2006-03-23
CA2581001C true CA2581001C (en) 2011-05-03

Family

ID=36273230

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2581001A Expired - Lifetime CA2581001C (en) 2004-09-15 2005-09-15 Kunitz-type recombinant inhibitor
CA002680759A Abandoned CA2680759A1 (en) 2004-09-15 2008-03-14 Kunitz-type recombinant inhibitor

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002680759A Abandoned CA2680759A1 (en) 2004-09-15 2008-03-14 Kunitz-type recombinant inhibitor

Country Status (10)

Country Link
US (1) US8440795B2 (enExample)
EP (1) EP1799707B1 (enExample)
JP (1) JP4980220B2 (enExample)
CN (1) CN101142232B (enExample)
AU (1) AU2005284615B2 (enExample)
BR (1) BRPI0406057B1 (enExample)
CA (2) CA2581001C (enExample)
DK (1) DK1799707T3 (enExample)
ES (1) ES2410160T3 (enExample)
WO (1) WO2006029492A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0406057B1 (pt) 2004-09-15 2021-10-26 União Química Farmacêutica Nacional S/A Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante
AU2008226358A1 (en) * 2007-03-14 2008-09-18 Ana Marisa Chudzinski-Tavassi Kunitz-type recombinant inhibitor
EP2379096B1 (en) * 2008-12-19 2019-10-30 Baxalta GmbH Tfpi inhibitors and methods of use
WO2010107991A2 (en) 2009-03-18 2010-09-23 Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer
BR102018074043A2 (pt) * 2018-11-22 2020-06-02 Inst Butantan composto para a modulação de vias de rlr, tlr, oas e/ou oncostatina m, uso do mesmo para a preparação de um medicamento, composição e método para modulação das ditas vias
BR102018074037A2 (pt) * 2018-11-22 2021-05-11 Inst Butantan composto para direcionar entidades moleculares para o domínio intracelular de células neoplásicas, ingrediente farmacêutico ativo compreendendo o referido composto, composição farmacêutica, método para o diagnóstico, prognóstico e/ou tratamento de câncer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3006207C2 (de) * 1980-02-15 1982-10-21 Siemens AG, 1000 Berlin und 8000 München Elektrische Maschine mit einem Ständerblechpaket aus kornorientierten Blechen
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
BRPI0406057B1 (pt) 2004-09-15 2021-10-26 União Química Farmacêutica Nacional S/A Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante

Also Published As

Publication number Publication date
EP1799707B1 (en) 2013-03-27
US8440795B2 (en) 2013-05-14
CA2581001A1 (en) 2006-03-23
BRPI0406057B1 (pt) 2021-10-26
AU2005284615B2 (en) 2011-03-31
WO2006029492A1 (en) 2006-03-23
US20090042786A1 (en) 2009-02-12
ES2410160T3 (es) 2013-07-01
DK1799707T3 (da) 2013-05-21
JP2008512992A (ja) 2008-05-01
CA2680759A1 (en) 2008-09-18
AU2005284615A1 (en) 2006-03-23
JP4980220B2 (ja) 2012-07-18
CN101142232A (zh) 2008-03-12
BRPI0406057A (pt) 2006-05-02
CN101142232B (zh) 2013-03-13
EP1799707A1 (en) 2007-06-27

Similar Documents

Publication Publication Date Title
US6689582B1 (en) Polynucleotide molecules encoding proteins having proteinase inhibitor activity
Jiang et al. Three pairs of protease-serpin complexes cooperatively regulate the insect innate immune responses
Mende et al. Dipetalogastin, a potent thrombin inhibitor from the blood‐sucking insectDipetalogaster maximus: cDNA cloning, expression and characterization
Zhang et al. Novel contact–kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke
WO2011036443A2 (en) Polypeptides and uses thereof
Huber-Lang et al. Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions
US8440795B2 (en) Kunitz-type recombinant inhibitor
JPH0584083A (ja) 新規ポリペプチド、それをコードする新規ｄｎａ、新規ポリペプチドの製造方法、新規医薬組成物、および新規酵素阻害方法
WO2009080054A1 (en) Protease inhibitor
AU2010299631A1 (en) Polypeptides and uses thereof
JP2012525836A (ja) セリンプロテアーゼインヒビターの改変方法
Ranasinghe et al. A novel coagulation inhibitor from Schistosoma japonicum
CN104789544B (zh) 重组pai-1抑制剂、包含其的组合物及其用于治疗和检测用途
Sun et al. Purification, cloning and characterization of a metalloproteinase from Naja atra venom
Kaiserman et al. Mechanisms of serpin dysfunction in disease
PL179215B1 (pl) sposób wytwarzania wyciagu i srodek farmaceutyczny PL PL PL PL PL PL PL PL
KR101296367B1 (ko) 프로테아제 억제 단백질 및 그 이용
EP2134843A1 (en) Kunitz-type recombinant inhibitor
CN110945020B (zh) 重组蛋白及其片段、生产所述重组蛋白的方法、合成基因以及重组蛋白的用途
JP4322922B2 (ja) Ｂｉｔｉｓａｒｉｅｔａｎｓのヘビ毒由来のトリプシン・インヒビター様タンパク質ｂｉｔｏｒａｎ、とその血液凝固因子Ｘａ阻害剤としての使用
TW200846356A (en) Preparation and use of variants of the kunitz domain 2 of the human placental bikunin gene
Debowski Natural proteinaceous inhibitors of serine proteases
CN106928334A (zh) 约安巨马陆抗血栓肽Joannsin及其应用
KR101374194B1 (ko) 대하로부터 분리한 쿠니츠형 세린 프로테아제 저해인자
Zhang et al. Identification and analysis of the tissue factor pathway inhibitor 2 of Sciaenops ocellatus

Legal Events

Date Code Title Description
EEER Examination request